NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,015,000 | +13.6% | 110,596 | +109.4% | 0.07% | +3.0% |
| Q1 2019 | $1,774,000 | +34.4% | 52,809 | +31.5% | 0.07% | +15.5% |
| Q4 2018 | $1,320,000 | -50.6% | 40,147 | -8.4% | 0.06% | -39.6% |
| Q3 2018 | $2,672,000 | +64.6% | 43,831 | +31.9% | 0.10% | +54.8% |
| Q2 2018 | $1,623,000 | +35.1% | 33,230 | +194.1% | 0.06% | +31.9% |
| Q1 2018 | $1,201,000 | -2.2% | 11,298 | -45.0% | 0.05% | -2.1% |
| Q4 2017 | $1,228,000 | +14.3% | 20,557 | -54.1% | 0.05% | +9.1% |
| Q3 2017 | $1,074,000 | +22.2% | 44,770 | -0.4% | 0.04% | +7.3% |
| Q2 2017 | $879,000 | -15.5% | 44,944 | +1.5% | 0.04% | -16.3% |
| Q1 2017 | $1,040,000 | – | 44,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |